Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer

Carmela Ricciardelli, Keiko Mayne, Pam Sykes, Wendy Raymond, Kieran McCaul, Villis Marshall, David Horsfall

    Research output: Contribution to journalArticle

    145 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)963-971
    JournalClinical Cancer Research
    Volume4
    Publication statusPublished - 1998

    Cite this

    Ricciardelli, C., Mayne, K., Sykes, P., Raymond, W., McCaul, K., Marshall, V., & Horsfall, D. (1998). Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer. Clinical Cancer Research, 4, 963-971.